Insider Transactions in Q3 2022 at Myriad Genetics Inc (MYGN)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 26
2022
|
Jayne B. Hart Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,216
-1.23%
|
$39,888
$18.41 P/Share
|
|
Sep 26
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,543
-1.11%
|
$81,774
$18.41 P/Share
|
|
Sep 26
2022
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
133
-0.31%
|
$2,394
$18.41 P/Share
|
|
Sep 26
2022
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,293
-0.96%
|
$41,274
$18.41 P/Share
|
|
Sep 26
2022
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,950
-1.21%
|
$53,100
$18.41 P/Share
|
|
Sep 26
2022
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
862
-0.98%
|
$15,516
$18.41 P/Share
|
|
Sep 25
2022
|
Jayne B. Hart Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,662
-0.92%
|
$29,916
$18.69 P/Share
|
|
Sep 25
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,263
-1.26%
|
$94,734
$18.69 P/Share
|
|
Sep 25
2022
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
345
-0.79%
|
$6,210
$18.69 P/Share
|
|
Sep 25
2022
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,793
-1.16%
|
$50,274
$18.69 P/Share
|
|
Sep 25
2022
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
642
-0.26%
|
$11,556
$18.69 P/Share
|
|
Sep 25
2022
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
346
-0.39%
|
$6,228
$18.69 P/Share
|
|
Sep 21
2022
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
702
-0.29%
|
$14,040
$20.2 P/Share
|
|
Aug 25
2022
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,031
-0.42%
|
$24,744
$24.89 P/Share
|
|
Aug 25
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,056
-0.73%
|
$73,344
$24.89 P/Share
|
|
Aug 25
2022
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
220
-0.87%
|
$5,280
$24.89 P/Share
|
|
Aug 25
2022
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,132
-0.46%
|
$27,168
$24.89 P/Share
|
|
Aug 25
2022
|
Jayne B. Hart Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,146
-0.63%
|
$27,504
$24.89 P/Share
|
|
Aug 15
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
2,150
-0.51%
|
-
|
|
Aug 13
2022
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
72,350
-3.16%
|
$1,953,450
$27.61 P/Share
|